COVID-19 and Liver Disease: An Evolving Landscape

Area of Science:

• Hepatology
• Infectious Diseases
• Internal Medicine

Background:

• The COVID-19 pandemic presents significant global health challenges, with respiratory symptoms being well-documented.
• The impact of COVID-19 on individuals with pre-existing liver diseases requires further investigation.
• COVID-19 can cause liver injury through multiple pathways and is linked to increased mortality in chronic liver disease patients.

Approach:

• This review synthesizes current knowledge on the relationship between COVID-19 and various liver conditions.
• It examines the mechanisms of COVID-19-induced liver injury.
• The review analyzes outcomes for patients with chronic liver disease, autoimmune hepatitis, and liver transplant recipients.

Key Points:

• COVID-19 exacerbates mortality risk in patients with chronic liver disease, correlating with disease severity.
• Liver transplant recipients may have more symptomatic COVID-19 but similar outcomes to the general population.
• COVID-19 vaccines are safe and effective for liver disease patients, despite potentially suboptimal immune responses; rare autoimmune hepatitis-like syndromes have been noted.

Conclusions:

• COVID-19 has profound implications for patients with liver diseases.
• Understanding these interactions is vital for clinical management.
• Prompt diagnosis and therapeutic interventions are essential for optimizing patient prognoses.